CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Revenue

In the year 2024, CanSino Biologics had annual revenue of 846.34M CNY with 137.01% growth. CanSino Biologics had revenue of 279.26M in the quarter ending December 31, 2024, with 53.90% growth.

• Revenue: 846.34M CNY
• Revenue Growth: +137.01%
• P/S Ratio: 10.02
• Revenue / Employee: 566.49K CNY
• Employees: 1,494
• Market Cap: 12.60B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	846.34M	489.25M	137.01%
Dec 31, 2023	357.08M	-677.51M	-65.49%
Dec 31, 2022	1.03B	-3.27B	-75.94%
Dec 31, 2021	4.30B	4.27B	17,174.82%
Dec 31, 2020	24.89M	22.61M	990.05%